IP Library Granted Patent US 7,166,705
Granted Patent B2
US 7,166,705 · App. 10/616,088 · Granted Jan 23, 2007

Histamine receptor antibody

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,166,705
App. No.
10/616,088
Granted
Jan 23, 2007
Kind
B2
Abstract

The present invention provides an isolated mammalian histamine receptor, isolated or recombinant nucleic acids and recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and methods of making the receptor using the host cells. This invention further provides antibodies and antigen binding fragments thereof which specifically bind to the receptor and are useful for treating medical conditions caused or mediated by histamine. Also provided are screening methods for identifying specific agonists and antagonists of the mammalian histamine receptor.

Claims (13)

1. An antibody or antigen-binding fragment thereof which specifically binds to the histamine receptor of SEQ ID NO: 2.

2. The antibody of claim 1 wherein said antibody is a monoclonal antibody.

3. The antibody of claim 1 wherein said antibody is a polyclonal antibody.

4. The antibody of claim 1 wherein said antibody is a neutralizing antibody.

5. The antigen-binding fragment of claim 1 wherein said fragment is selected from the group consisting of a Fab, a Fc, a F(ab) 2 , and a Fv fragment.

6. The antibody or antigen-binding fragment of claim 1 wherein said antibody or fragment further comprises a detectable label.

7. The antibody or antigen-binding fragment of claim 6 wherein said label is selected from the group consisting of a radiolabel, a fluroescent label, a chemiluminescent label, and an enzymatic label.

8. A hybridoma comprising the antibody of claim 2 .

9. A phage comprising the antibody of claim 2 .

10. A pharmaceutical composition comprising the antibody or antigen-binding fragment thereof of claim 1 .

11. A pharmaceutical composition comprising the antibody of claim 2 .

12. A pharmaceutical composition comprising the antibody of claim 4 .

13. A pharmaceutical composition comprising the antigen-binding fragment of claim 5 .

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →